| 0 |
IMPLANTABLE CARDIAC MONITOR REPLACEMENT |
1 |
0.1429 |
| 1 |
CONGENITAL KNEE DISLOCATION |
1 |
0.0250 |
| 2 |
TRAUMATIC PAIN |
1 |
0.0238 |
| 3 |
SECOND DEGREE CHEMICAL BURN OF SKIN |
1 |
0.0167 |
| 4 |
FOREIGN BODY IN SKIN OR SUBCUTANEOUS TISSUE |
1 |
0.0145 |
| 5 |
BLAST CELL COUNT DECREASED |
1 |
0.0137 |
| 6 |
APPLICATION SITE HYPERAESTHESIA |
1 |
0.0101 |
| 7 |
GENITAL DISCOMFORT |
2 |
0.0036 |
| 8 |
IODINE ALLERGY |
1 |
0.0030 |
| 9 |
POLYCYSTIC OVARIAN SYNDROME |
1 |
0.0026 |
| 10 |
B PRECURSOR TYPE ACUTE LEUKAEMIA |
1 |
0.0026 |
| 11 |
CONGENITAL MUSCULOSKELETAL ANOMALY |
1 |
0.0023 |
| 12 |
PRODUCT WITH QUALITY ISSUE ADMINISTERED |
1 |
0.0022 |
| 13 |
APPLICATION SITE DISCOMFORT |
4 |
0.0022 |
| 14 |
PLICATED TONGUE |
1 |
0.0021 |
| 15 |
PILONIDAL CYST |
1 |
0.0020 |
| 16 |
STEATOHEPATITIS |
1 |
0.0019 |
| 17 |
CHEMICAL BURN |
2 |
0.0017 |
| 18 |
CERVICOBRACHIAL SYNDROME |
1 |
0.0016 |
| 19 |
INFUSION SITE URTICARIA |
1 |
0.0015 |
| 20 |
PRECANCEROUS CONDITION |
1 |
0.0015 |
| 21 |
CYST RUPTURE |
1 |
0.0015 |
| 22 |
ANGULAR CHEILITIS |
1 |
0.0014 |
| 23 |
PERIORBITAL PAIN |
1 |
0.0012 |
| 24 |
APPLICATION SITE DRYNESS |
4 |
0.0012 |
| 25 |
POUCHITIS |
1 |
0.0012 |
| 26 |
APPLICATION SITE DERMATITIS |
1 |
0.0011 |
| 27 |
INFUSION SITE DISCOMFORT |
1 |
0.0010 |
| 28 |
PERTUSSIS |
1 |
0.0010 |
| 29 |
TEETH BRITTLE |
1 |
0.0010 |
| 30 |
SUPERFICIAL INJURY OF EYE |
1 |
0.0009 |
| 31 |
INTRUSIVE THOUGHTS |
1 |
0.0008 |
| 32 |
INFECTED CYST |
1 |
0.0008 |
| 33 |
UPPER RESPIRATORY TRACT INFLAMMATION |
1 |
0.0008 |
| 34 |
DYSFUNCTIONAL UTERINE BLEEDING |
1 |
0.0008 |
| 35 |
XEROSIS |
1 |
0.0008 |
| 36 |
WHITE MATTER LESION |
1 |
0.0008 |
| 37 |
APPLICATION SITE WARMTH |
1 |
0.0008 |
| 38 |
APPLICATION SITE PAIN |
17 |
0.0008 |
| 39 |
APPLICATION SITE PARAESTHESIA |
1 |
0.0008 |
| 40 |
SKIN DISCOMFORT |
2 |
0.0007 |
| 41 |
APPLICATION SITE DISCOLOURATION |
3 |
0.0007 |
| 42 |
SIALOADENITIS |
1 |
0.0007 |
| 43 |
INFUSION SITE RASH |
1 |
0.0007 |
| 44 |
APPLICATION SITE RASH |
10 |
0.0007 |
| 45 |
PRODUCT PHYSICAL CONSISTENCY ISSUE |
4 |
0.0007 |
| 46 |
ALVEOLITIS |
1 |
0.0007 |
| 47 |
GLOMERULAR FILTRATION RATE ABNORMAL |
1 |
0.0007 |
| 48 |
SLEEP PARALYSIS |
1 |
0.0007 |
| 49 |
GENITAL PAIN |
1 |
0.0007 |
| 50 |
AXILLARY PAIN |
1 |
0.0007 |
| 51 |
PULMONARY FUNCTION TEST ABNORMAL |
1 |
0.0006 |
| 52 |
ELECTROCARDIOGRAM T WAVE ABNORMAL |
1 |
0.0006 |
| 53 |
OPHTHALMOPLEGIA |
1 |
0.0006 |
| 54 |
APPLICATION SITE BURN |
3 |
0.0006 |
| 55 |
APPLICATION SITE SWELLING |
3 |
0.0006 |
| 56 |
BLOOD CALCIUM ABNORMAL |
1 |
0.0006 |
| 57 |
PRODUCT CONTAINER SEAL ISSUE |
1 |
0.0006 |
| 58 |
PRODUCT ODOUR ABNORMAL |
6 |
0.0006 |
| 59 |
INFUSION SITE DISCHARGE |
1 |
0.0006 |
| 60 |
NASAL OEDEMA |
1 |
0.0006 |
| 61 |
HIDRADENITIS |
5 |
0.0005 |
| 62 |
BLADDER SPASM |
1 |
0.0005 |
| 63 |
LIP DISORDER |
1 |
0.0005 |
| 64 |
APPLICATION SITE ERYTHEMA |
13 |
0.0005 |
| 65 |
EYELID PAIN |
1 |
0.0005 |
| 66 |
APPLICATION SITE EXFOLIATION |
2 |
0.0005 |
| 67 |
SKIN INDURATION |
1 |
0.0005 |
| 68 |
DEVICE CONNECTION ISSUE |
1 |
0.0005 |
| 69 |
PRODUCT DISPENSING ISSUE |
2 |
0.0005 |
| 70 |
PRODUCT PACKAGE ASSOCIATED INJURY |
1 |
0.0004 |
| 71 |
APPLICATION SITE URTICARIA |
1 |
0.0004 |
| 72 |
APPLICATION SITE IRRITATION |
5 |
0.0004 |
| 73 |
EYELID IRRITATION |
1 |
0.0004 |
| 74 |
PRODUCT CONTAMINATION PHYSICAL |
1 |
0.0004 |
| 75 |
CATHETER SITE PAIN |
1 |
0.0004 |
| 76 |
PROTEIN TOTAL INCREASED |
1 |
0.0004 |
| 77 |
LIP BLISTER |
1 |
0.0004 |
| 78 |
STREPTOCOCCAL INFECTION |
2 |
0.0004 |
| 79 |
INFUSION SITE ERYTHEMA |
3 |
0.0004 |
| 80 |
PERIORBITAL SWELLING |
2 |
0.0004 |
| 81 |
DEVICE POWER SOURCE ISSUE |
1 |
0.0003 |
| 82 |
ACNE CYSTIC |
1 |
0.0003 |
| 83 |
SWELLING OF EYELID |
2 |
0.0003 |
| 84 |
INFUSION SITE PRURITUS |
1 |
0.0003 |
| 85 |
BLADDER PAIN |
1 |
0.0003 |
| 86 |
VULVOVAGINAL DRYNESS |
1 |
0.0003 |
| 87 |
LYME DISEASE |
1 |
0.0003 |
| 88 |
PLANTAR FASCIITIS |
1 |
0.0003 |
| 89 |
WOUND DEHISCENCE |
1 |
0.0003 |
| 90 |
SKIN WEEPING |
1 |
0.0003 |
| 91 |
WOUND HAEMORRHAGE |
1 |
0.0003 |
| 92 |
APPLICATION SITE PRURITUS |
6 |
0.0003 |
| 93 |
GASTRIC INFECTION |
1 |
0.0003 |
| 94 |
REHABILITATION THERAPY |
1 |
0.0003 |
| 95 |
THERAPEUTIC PRODUCT EFFECT VARIABLE |
1 |
0.0003 |
| 96 |
WOUND SECRETION |
1 |
0.0003 |
| 97 |
GINGIVAL PAIN |
2 |
0.0003 |
| 98 |
OESOPHAGEAL CANDIDIASIS |
1 |
0.0003 |
| 99 |
FUNGAL SKIN INFECTION |
1 |
0.0002 |
| 100 |
RECURRENT CANCER |
1 |
0.0002 |
| 101 |
DEMYELINATION |
1 |
0.0002 |
| 102 |
TONGUE DISCOMFORT |
1 |
0.0002 |
| 103 |
ABSCESS LIMB |
1 |
0.0002 |
| 104 |
METASTATIC NEOPLASM |
1 |
0.0002 |
| 105 |
CHAPPED LIPS |
1 |
0.0002 |
| 106 |
BONE CANCER |
1 |
0.0002 |
| 107 |
PARONYCHIA |
1 |
0.0002 |
| 108 |
URINARY TRACT DISORDER |
1 |
0.0002 |
| 109 |
LIP DRY |
2 |
0.0002 |
| 110 |
RENAL FUNCTION TEST ABNORMAL |
1 |
0.0002 |
| 111 |
ROSACEA |
1 |
0.0002 |
| 112 |
SKIN TIGHTNESS |
1 |
0.0002 |
| 113 |
VAGINAL INFECTION |
1 |
0.0002 |
| 114 |
EXPIRED PRODUCT ADMINISTERED |
7 |
0.0002 |
| 115 |
ENDOMETRIOSIS |
1 |
0.0002 |
| 116 |
SUBCUTANEOUS ABSCESS |
1 |
0.0002 |
| 117 |
TUMOUR MARKER INCREASED |
1 |
0.0002 |
| 118 |
ENDOCARDITIS |
1 |
0.0002 |
| 119 |
NYSTAGMUS |
1 |
0.0002 |
| 120 |
GASTROINTESTINAL MOTILITY DISORDER |
1 |
0.0002 |
| 121 |
PRODUCT RESIDUE PRESENT |
1 |
0.0002 |
| 122 |
ERYTHEMA OF EYELID |
1 |
0.0002 |
| 123 |
PROSTATIC DISORDER |
1 |
0.0002 |
| 124 |
INTERMENSTRUAL BLEEDING |
1 |
0.0002 |
| 125 |
MACULAR OEDEMA |
1 |
0.0002 |
| 126 |
PERIPHERAL SENSORY NEUROPATHY |
1 |
0.0002 |
| 127 |
DECREASED INTEREST |
1 |
0.0002 |
| 128 |
PHARYNGITIS |
2 |
0.0002 |
| 129 |
PRE-EXISTING CONDITION IMPROVED |
1 |
0.0002 |
| 130 |
INFUSION SITE PAIN |
2 |
0.0002 |
| 131 |
INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION |
11 |
0.0002 |
| 132 |
POLYP |
1 |
0.0002 |
| 133 |
APPETITE DISORDER |
1 |
0.0002 |
| 134 |
ADVERSE REACTION |
2 |
0.0002 |
| 135 |
MENINGITIS |
1 |
0.0001 |
| 136 |
LYMPHOEDEMA |
1 |
0.0001 |
| 137 |
PAPULE |
1 |
0.0001 |
| 138 |
THERMAL BURN |
1 |
0.0001 |
| 139 |
DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE |
1 |
0.0001 |
| 140 |
IMPAIRED QUALITY OF LIFE |
2 |
0.0001 |
| 141 |
FAECES SOFT |
1 |
0.0001 |
| 142 |
COLON CANCER |
2 |
0.0001 |
| 143 |
AORTIC ANEURYSM |
1 |
0.0001 |
| 144 |
INSURANCE ISSUE |
2 |
0.0001 |
| 145 |
FOOD ALLERGY |
1 |
0.0001 |
| 146 |
MYASTHENIA GRAVIS |
1 |
0.0001 |
| 147 |
HYPERAESTHESIA |
1 |
0.0001 |
| 148 |
UPPER-AIRWAY COUGH SYNDROME |
1 |
0.0001 |
| 149 |
ACNE |
9 |
0.0001 |
| 150 |
SKIN PLAQUE |
1 |
0.0001 |
| 151 |
HYSTERECTOMY |
1 |
0.0001 |
| 152 |
LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR |
1 |
0.0001 |
| 153 |
FACIAL PAIN |
1 |
0.0001 |
| 154 |
RESTLESS LEGS SYNDROME |
2 |
0.0001 |
| 155 |
INTERVERTEBRAL DISC DEGENERATION |
1 |
0.0001 |
| 156 |
PRODUCT DISTRIBUTION ISSUE |
1 |
0.0001 |
| 157 |
EYE SWELLING |
4 |
0.0001 |
| 158 |
BACTERIAL INFECTION |
2 |
0.0001 |
| 159 |
HEPATIC ENCEPHALOPATHY |
1 |
0.0001 |
| 160 |
PRODUCT PACKAGING ISSUE |
1 |
0.0001 |
| 161 |
VITAMIN D DEFICIENCY |
1 |
0.0001 |
| 162 |
SKIN FISSURES |
2 |
0.0001 |
| 163 |
BLADDER DISORDER |
1 |
0.0001 |
| 164 |
BURNING SENSATION |
7 |
0.0001 |
| 165 |
POOR VENOUS ACCESS |
1 |
0.0001 |
| 166 |
POOR QUALITY PRODUCT ADMINISTERED |
1 |
0.0001 |
| 167 |
JOINT DISLOCATION |
1 |
0.0001 |
| 168 |
RETCHING |
2 |
0.0001 |
| 169 |
HEREDITARY ANGIOEDEMA |
1 |
0.0001 |
| 170 |
SKIN LACERATION |
1 |
0.0001 |
| 171 |
DENTAL CARIES |
1 |
0.0001 |
| 172 |
THERAPEUTIC PRODUCT EFFECT DECREASED |
4 |
0.0001 |
| 173 |
SKIN INFECTION |
1 |
0.0001 |
| 174 |
PRODUCT AVAILABILITY ISSUE |
2 |
0.0001 |
| 175 |
METASTASES TO LUNG |
1 |
0.0001 |
| 176 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
15 |
0.0001 |
| 177 |
INJECTION SITE DISCOLOURATION |
1 |
0.0001 |
| 178 |
SECRETION DISCHARGE |
1 |
0.0001 |
| 179 |
INJECTION SITE IRRITATION |
1 |
0.0001 |
| 180 |
ERYTHEMA |
16 |
0.0001 |
| 181 |
RESPIRATORY TRACT INFECTION |
2 |
0.0001 |
| 182 |
DEAFNESS |
2 |
0.0001 |
| 183 |
ORAL CANDIDIASIS |
1 |
0.0001 |
| 184 |
ANKYLOSING SPONDYLITIS |
1 |
0.0001 |
| 185 |
SARS-COV-2 TEST POSITIVE |
1 |
0.0001 |
| 186 |
EAR INFECTION |
2 |
0.0001 |
| 187 |
PAIN OF SKIN |
2 |
0.0001 |
| 188 |
DRUG EFFECT DECREASED |
4 |
0.0001 |
| 189 |
UVEITIS |
1 |
0.0001 |
| 190 |
IMPAIRED GASTRIC EMPTYING |
1 |
0.0001 |
| 191 |
SKIN EXFOLIATION |
6 |
0.0001 |
| 192 |
DEVICE OCCLUSION |
1 |
0.0001 |
| 193 |
SKIN REACTION |
1 |
0.0001 |
| 194 |
SEASONAL ALLERGY |
1 |
0.0001 |
| 195 |
SKIN BURNING SENSATION |
5 |
0.0001 |
| 196 |
CONDITION AGGRAVATED |
21 |
0.0001 |
| 197 |
LABORATORY TEST ABNORMAL |
2 |
0.0001 |
| 198 |
SKIN HAEMORRHAGE |
1 |
0.0001 |
| 199 |
DRY SKIN |
9 |
0.0001 |
| 200 |
ECONOMIC PROBLEM |
1 |
0.0001 |
| 201 |
SKIN IRRITATION |
3 |
0.0001 |
| 202 |
RASH ERYTHEMATOUS |
3 |
0.0001 |
| 203 |
SCIATICA |
1 |
0.0001 |
| 204 |
SWELLING FACE |
4 |
0.0001 |
| 205 |
PHOTOSENSITIVITY REACTION |
1 |
0.0001 |
| 206 |
FUNGAL INFECTION |
2 |
0.0001 |
| 207 |
HEMIPARESIS |
1 |
0.0001 |
| 208 |
SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION |
1 |
0.0001 |
| 209 |
SCAR |
1 |
0.0001 |
| 210 |
DEVICE DEFECTIVE |
1 |
0.0001 |
| 211 |
ECZEMA |
3 |
0.0001 |
| 212 |
RASH MACULAR |
2 |
0.0001 |
| 213 |
BLOOD TRIGLYCERIDES INCREASED |
1 |
0.0001 |
| 214 |
RASH PRURITIC |
3 |
0.0001 |
| 215 |
PELVIC PAIN |
1 |
0.0001 |
| 216 |
ACCIDENTAL OVERDOSE |
2 |
0.0001 |
| 217 |
CONJUNCTIVITIS |
1 |
0.0001 |
| 218 |
DYSTONIA |
1 |
0.0001 |
| 219 |
ORAL HERPES |
1 |
0.0001 |
| 220 |
ABORTION SPONTANEOUS |
2 |
0.0000 |
| 221 |
PRODUCT PHYSICAL ISSUE |
1 |
0.0000 |
| 222 |
PRODUCT ADMINISTRATION ERROR |
1 |
0.0000 |
| 223 |
TASTE DISORDER |
1 |
0.0000 |
| 224 |
RIB FRACTURE |
1 |
0.0000 |
| 225 |
DERMATITIS |
1 |
0.0000 |
| 226 |
KNEE ARTHROPLASTY |
1 |
0.0000 |
| 227 |
MOUTH ULCERATION |
1 |
0.0000 |
| 228 |
EATING DISORDER |
1 |
0.0000 |
| 229 |
IMPAIRED WORK ABILITY |
1 |
0.0000 |
| 230 |
IRRITABLE BOWEL SYNDROME |
1 |
0.0000 |
| 231 |
LIVER FUNCTION TEST INCREASED |
1 |
0.0000 |
| 232 |
CLOSTRIDIUM DIFFICILE INFECTION |
1 |
0.0000 |
| 233 |
GAMMA-GLUTAMYLTRANSFERASE INCREASED |
1 |
0.0000 |
| 234 |
TOOTH DISORDER |
1 |
0.0000 |
| 235 |
GLOSSODYNIA |
1 |
0.0000 |
| 236 |
RASH PAPULAR |
1 |
0.0000 |
| 237 |
SNEEZING |
1 |
0.0000 |
| 238 |
THERAPEUTIC RESPONSE UNEXPECTED |
2 |
0.0000 |
| 239 |
THROAT IRRITATION |
2 |
0.0000 |
| 240 |
ASTHMA |
5 |
0.0000 |
| 241 |
PRODUCT DOSE OMISSION ISSUE |
13 |
0.0000 |
| 242 |
SKIN DISCOLOURATION |
2 |
0.0000 |
| 243 |
PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME |
1 |
0.0000 |
| 244 |
MENTAL IMPAIRMENT |
1 |
0.0000 |
| 245 |
NEURALGIA |
1 |
0.0000 |
| 246 |
BRONCHITIS |
3 |
0.0000 |
| 247 |
CELLULITIS |
2 |
0.0000 |
| 248 |
PRURITUS |
15 |
0.0000 |
| 249 |
EXPOSURE VIA SKIN CONTACT |
1 |
0.0000 |
| 250 |
DIPLOPIA |
1 |
0.0000 |
| 251 |
MUCOSAL INFLAMMATION |
1 |
0.0000 |
| 252 |
SEDATION |
1 |
0.0000 |
| 253 |
ANHEDONIA |
1 |
0.0000 |
| 254 |
GASTRITIS |
1 |
0.0000 |
| 255 |
FREQUENT BOWEL MOVEMENTS |
1 |
0.0000 |
| 256 |
PNEUMONITIS |
1 |
0.0000 |
| 257 |
TREATMENT NONCOMPLIANCE |
2 |
0.0000 |
| 258 |
DRUG INEFFECTIVE |
48 |
0.0000 |
| 259 |
ABNORMAL DREAMS |
1 |
0.0000 |
| 260 |
TREATMENT FAILURE |
3 |
0.0000 |
| 261 |
DIVERTICULITIS |
1 |
0.0000 |
| 262 |
PROCEDURAL PAIN |
1 |
0.0000 |
| 263 |
ARTHROPATHY |
2 |
0.0000 |
| 264 |
FEELING COLD |
1 |
0.0000 |
| 265 |
HAEMOPTYSIS |
1 |
0.0000 |
| 266 |
URTICARIA |
6 |
0.0000 |
| 267 |
BLISTER |
2 |
0.0000 |
| 268 |
EYE PAIN |
2 |
0.0000 |
| 269 |
INTENTIONAL DOSE OMISSION |
1 |
0.0000 |
| 270 |
INTERNATIONAL NORMALISED RATIO INCREASED |
1 |
0.0000 |
| 271 |
DRUG EFFECTIVE FOR UNAPPROVED INDICATION |
1 |
0.0000 |
| 272 |
SURGERY |
2 |
0.0000 |
| 273 |
MATERNAL EXPOSURE DURING PREGNANCY |
3 |
0.0000 |
| 274 |
CATARACT |
2 |
0.0000 |
| 275 |
IRRITABILITY |
2 |
0.0000 |
| 276 |
BLOOD POTASSIUM DECREASED |
1 |
0.0000 |
| 277 |
LACRIMATION INCREASED |
1 |
0.0000 |
| 278 |
VERTIGO |
2 |
0.0000 |
| 279 |
EPILEPSY |
1 |
0.0000 |
| 280 |
EXPOSURE DURING PREGNANCY |
2 |
0.0000 |
| 281 |
HEAD INJURY |
1 |
0.0000 |
| 282 |
RHINORRHOEA |
2 |
0.0000 |
| 283 |
IMPAIRED HEALING |
1 |
0.0000 |
| 284 |
STAPHYLOCOCCAL INFECTION |
1 |
0.0000 |
| 285 |
LIP SWELLING |
1 |
0.0000 |
| 286 |
SKIN DISORDER |
1 |
0.0000 |
| 287 |
TYPE 2 DIABETES MELLITUS |
1 |
0.0000 |
| 288 |
ANGER |
1 |
0.0000 |
| 289 |
ILLNESS |
3 |
0.0000 |
| 290 |
NEOPLASM PROGRESSION |
1 |
0.0000 |
| 291 |
ABDOMINAL DISTENSION |
3 |
0.0000 |
| 292 |
COVID-19 |
5 |
0.0000 |
| 293 |
THERAPY INTERRUPTED |
2 |
0.0000 |
| 294 |
DRUG EFFECT INCOMPLETE |
1 |
0.0000 |
| 295 |
RASH |
12 |
0.0000 |
| 296 |
C-REACTIVE PROTEIN INCREASED |
1 |
0.0000 |
| 297 |
HYPERGLYCAEMIA |
1 |
0.0000 |
| 298 |
DYSURIA |
1 |
0.0000 |
| 299 |
HYPERSENSITIVITY |
5 |
0.0000 |
| 300 |
EPISTAXIS |
2 |
0.0000 |
| 301 |
DEPRESSION |
6 |
0.0000 |
| 302 |
PERIPHERAL SWELLING |
4 |
0.0000 |
| 303 |
EXTRA DOSE ADMINISTERED |
1 |
0.0000 |
| 304 |
PSORIATIC ARTHROPATHY |
1 |
0.0000 |
| 305 |
BLINDNESS |
1 |
0.0000 |
| 306 |
DEVICE LEAKAGE |
1 |
0.0000 |
| 307 |
PRODUCT STORAGE ERROR |
2 |
0.0000 |
| 308 |
INTENTIONAL PRODUCT USE ISSUE |
2 |
0.0000 |
| 309 |
INJECTION SITE PAIN |
7 |
0.0000 |
| 310 |
GASTROINTESTINAL DISORDER |
2 |
0.0000 |
| 311 |
THERAPY NON-RESPONDER |
1 |
0.0000 |
| 312 |
PRODUCT QUALITY ISSUE |
3 |
0.0000 |
| 313 |
SUICIDAL IDEATION |
2 |
0.0000 |
| 314 |
NEPHROLITHIASIS |
1 |
0.0000 |
| 315 |
HYPOKALAEMIA |
1 |
0.0000 |
| 316 |
COGNITIVE DISORDER |
1 |
0.0000 |
| 317 |
OCULAR HYPERAEMIA |
1 |
0.0000 |
| 318 |
PRODUCTIVE COUGH |
1 |
0.0000 |
| 319 |
HYPOGLYCAEMIA |
1 |
0.0000 |
| 320 |
FLUID RETENTION |
1 |
0.0000 |
| 321 |
CHEST DISCOMFORT |
2 |
0.0000 |
| 322 |
SINUSITIS |
2 |
0.0000 |
| 323 |
INFLAMMATION |
1 |
0.0000 |
| 324 |
DERMATITIS ATOPIC |
1 |
0.0000 |
| 325 |
ASPARTATE AMINOTRANSFERASE INCREASED |
1 |
0.0000 |
| 326 |
OEDEMA |
1 |
0.0000 |
| 327 |
ANAPHYLACTIC REACTION |
1 |
0.0000 |
| 328 |
FALL |
6 |
0.0000 |
| 329 |
FLATULENCE |
1 |
0.0000 |
| 330 |
URINARY TRACT INFECTION |
3 |
0.0000 |
| 331 |
HERPES ZOSTER |
1 |
0.0000 |
| 332 |
EYE IRRITATION |
1 |
0.0000 |
| 333 |
DYSPHONIA |
1 |
0.0000 |
| 334 |
NASAL CONGESTION |
1 |
0.0000 |
| 335 |
WHEEZING |
1 |
0.0000 |
| 336 |
EMOTIONAL DISTRESS |
2 |
0.0000 |
| 337 |
THERAPEUTIC RESPONSE DECREASED |
1 |
0.0000 |
| 338 |
DISCOMFORT |
1 |
0.0000 |
| 339 |
ALANINE AMINOTRANSFERASE INCREASED |
1 |
0.0000 |
| 340 |
PAIN |
10 |
0.0000 |
| 341 |
NASOPHARYNGITIS |
3 |
0.0000 |
| 342 |
VISUAL IMPAIRMENT |
2 |
0.0000 |
| 343 |
HEADACHE |
10 |
0.0000 |
| 344 |
DEVICE EXPULSION |
1 |
0.0000 |
| 345 |
BLOOD CREATININE INCREASED |
1 |
0.0000 |
| 346 |
PSORIASIS |
2 |
0.0000 |
| 347 |
SOMNOLENCE |
3 |
0.0000 |
| 348 |
WEIGHT DECREASED |
4 |
0.0000 |
| 349 |
COUGH |
4 |
0.0000 |
| 350 |
INJURY |
1 |
0.0000 |
| 351 |
SLEEP DISORDER |
1 |
0.0000 |
| 352 |
HYPERTENSION |
3 |
0.0000 |
| 353 |
MOBILITY DECREASED |
1 |
0.0000 |
| 354 |
NAUSEA |
11 |
0.0000 |
| 355 |
HOT FLUSH |
1 |
0.0000 |
| 356 |
INCORRECT DOSE ADMINISTERED |
3 |
0.0000 |
| 357 |
ARTHRITIS |
1 |
0.0000 |
| 358 |
INJECTION SITE HAEMORRHAGE |
1 |
0.0000 |
| 359 |
FEELING ABNORMAL |
3 |
0.0000 |
| 360 |
GASTROOESOPHAGEAL REFLUX DISEASE |
1 |
0.0000 |
| 361 |
DIARRHOEA |
8 |
0.0000 |
| 362 |
FOETAL EXPOSURE DURING PREGNANCY |
1 |
0.0000 |
| 363 |
ABDOMINAL DISCOMFORT |
2 |
0.0000 |
| 364 |
RENAL IMPAIRMENT |
1 |
0.0000 |
| 365 |
BALANCE DISORDER |
1 |
0.0000 |
| 366 |
FATIGUE |
9 |
0.0000 |
| 367 |
MUSCULOSKELETAL STIFFNESS |
1 |
0.0000 |
| 368 |
INSOMNIA |
3 |
0.0000 |
| 369 |
DEVICE ISSUE |
1 |
0.0000 |
| 370 |
NO ADVERSE EVENT |
2 |
0.0000 |
| 371 |
OROPHARYNGEAL PAIN |
1 |
0.0000 |
| 372 |
CARDIAC DISORDER |
1 |
0.0000 |
| 373 |
SWELLING |
1 |
0.0000 |
| 374 |
PRODUCT USE ISSUE |
2 |
0.0000 |
| 375 |
ANXIETY |
3 |
0.0000 |
| 376 |
DYSPHAGIA |
1 |
0.0000 |
| 377 |
NEUROPATHY PERIPHERAL |
1 |
0.0000 |
| 378 |
MIGRAINE |
1 |
0.0000 |
| 379 |
GAIT DISTURBANCE |
2 |
0.0000 |
| 380 |
ALOPECIA |
2 |
0.0000 |
| 381 |
DYSPEPSIA |
1 |
0.0000 |
| 382 |
SYNCOPE |
1 |
0.0000 |
| 383 |
ACCIDENTAL EXPOSURE TO PRODUCT |
1 |
0.0000 |
| 384 |
WHITE BLOOD CELL COUNT DECREASED |
1 |
0.0000 |
| 385 |
CONSTIPATION |
2 |
0.0000 |
| 386 |
INFLUENZA |
1 |
0.0000 |
| 387 |
WEIGHT INCREASED |
2 |
0.0000 |
| 388 |
MUSCULAR WEAKNESS |
1 |
0.0000 |
| 389 |
PYREXIA |
3 |
0.0000 |
| 390 |
SEIZURE |
1 |
0.0000 |
| 391 |
GENERAL PHYSICAL HEALTH DETERIORATION |
1 |
0.0000 |
| 392 |
CHILLS |
1 |
0.0000 |
| 393 |
JOINT SWELLING |
1 |
0.0000 |
| 394 |
OFF LABEL USE |
7 |
0.0000 |
| 395 |
ASTHENIA |
3 |
0.0000 |
| 396 |
RENAL FAILURE |
1 |
0.0000 |
| 397 |
DEHYDRATION |
1 |
0.0000 |
| 398 |
NEUTROPENIA |
1 |
0.0000 |
| 399 |
ARTHRALGIA |
3 |
0.0000 |
| 400 |
DYSPNOEA |
4 |
0.0000 |
| 401 |
MALAISE |
3 |
0.0000 |
| 402 |
PAIN IN EXTREMITY |
2 |
0.0000 |
| 403 |
VOMITING |
3 |
0.0000 |
| 404 |
CONFUSIONAL STATE |
1 |
0.0000 |
| 405 |
PNEUMONIA |
2 |
0.0000 |
| 406 |
DIZZINESS |
3 |
0.0000 |
| 407 |
MYALGIA |
1 |
0.0000 |
| 408 |
CHEST PAIN |
1 |
0.0000 |
| 409 |
ANAEMIA |
1 |
0.0000 |
| 410 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
1 |
0.0000 |
| 411 |
OVERDOSE |
1 |
0.0000 |
| 412 |
BACK PAIN |
1 |
0.0000 |
| 413 |
ABDOMINAL PAIN |
1 |
0.0000 |
| 414 |
PRODUCT USE IN UNAPPROVED INDICATION |
1 |
0.0000 |